(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. LvAlx1 is required in macromere descendants for transfating.
(A) Experimental protocol. (B-I) Embryos were immunostained with
mAb 6a9 and the same embryos were photographed using both brightfield (left
column) and epifluorescence (right column) optics. (B,C) Control late gastrula
stage embryo, 20 hours postfertilization. (D,E) LvAlx1 MO-injected embryo, 48
hours postfertilization. Most morphogenetic processes are unaffected by LvAlx1
knockdown but the embryo lacks 6a9-positive cells and skeletal elements. (F,G)
Micromere-deficient [micromere(-)] embryo, 24 hours postfertilization.
Transfating has occurred, leading to the formation of many 6a9-positive cells
(arrow) and two skeletal primordia. (H,I) LvAlx1 MO-injected,
micromere-deficient embryo, 48 postfertilization. The embryo has undergone
extensive morphogenetic changes but lacks 6a9-positive cells and a
skeleton.